Toronto Dominion Bank Oncolytics Biotech Inc Transaction History

Toronto Dominion Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.99 - $1.24 $469 - $587	474 New	474 $0
Q4 2023 Feb 13, 2024	BUY	$1.22 - $2.09 $4,335 - $7,427	3,554 New	3,554 $4,000
Q2 2023 Feb 14, 2024	SELL	$1.11 - $2.74 $3,835 - $9,466	-3,455 Reduced 97.21%	99 $0
Q2 2023 Aug 10, 2023	BUY	$1.11 - $2.74 $49 - $123	45 Added 83.33%	99 $0
Q1 2023 May 11, 2023	BUY	$1.2 - $1.91 $64 - $103	54 New	54 $0
Q2 2022 Aug 11, 2022	BUY	$0.85 - $1.59 $30,057 - $56,225	35,362 New	35,362 $34,000
Q1 2022 May 09, 2022	SELL	$1.31 - $2.02 $6,751 - $10,411	-5,154 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$1.39 - $2.3 $5,348 - $8,850	3,848 Added 294.64%	5,154 $7,000
Q3 2021 Nov 08, 2021	SELL	$1.93 - $2.77 $2,497 - $3,584	-1,294 Reduced 49.77%	1,306 $3,000
Q2 2021 Aug 13, 2021	BUY	$2.6 - $4.64 $6,760 - $12,064	2,600 New	2,600 $7,000

1.25M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $42.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.